Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China flag China · Delayed Price · Currency is CNY
9.31
+0.11 (1.20%)
Sep 14, 2026, 3:04 PM CST

Yifan Pharmaceutical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
4,9655,1335,1604,0683,8374,409
Revenue Growth
-3.82%-0.52%26.84%6.03%-12.98%-18.36%
Gross Profit
2,2322,3762,4141,9291,8531,815
Operating Income
350.68441.78388.5220.93171.35262.68
Net Income
303.4402.02385.97-551.07191.22278.4
Earnings Per Share
0.250.330.32-0.450.150.23
EPS Growth
-30.85%3.13%---34.78%-70.89%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Pharmaceutical Products Division
4,367
Offset of Business Segment
-9.55
Pharmaceutical Raw Materials and Polymers
775.05
Total
5,133

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
884.25732.97889.39773.381,2391,336
Total Debt
2,4682,3632,2941,9952,1772,274
Net Cash (Debt)
-1,583-1,630-1,405-1,222-937.51-937.76
Net Cash Growth
------
Net Cash Per Share
-1.30-1.34-1.16-1.00-0.74-0.77

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
765.78458.37640.73348.58472.07301.23
Capital Expenditures
-688.07-559.23-628.16-504.09-542.27-571.74
Free Cash Flow
77.71-100.8712.57-155.5-70.21-270.51
Free Cash Flow Growth
-52.35%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
44.94%46.29%46.79%47.42%48.30%41.16%
Operating Margin
7.06%8.61%7.53%0.52%4.47%5.96%
Pretax Margin
6.22%8.25%7.53%-21.36%4.09%4.78%
Profit Margin
6.11%7.83%7.48%-13.55%4.98%6.31%
FCF Margin
1.57%-1.97%0.24%-3.82%-1.83%-6.13%

Dividends

Fiscal YearCurrentFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Dividend Per Share
0.1000.1000.200
Dividend Per Share Growth
-50.00%-50.00%-
Dividend Yield
1.03%0.84%1.90%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
37.3830.8433.78-78.5478.11
Forward PE
25.1620.3620.8233.5916.3332.78
P/FCF Ratio
124.20-1037.05---
PS Ratio
1.942.422.534.433.924.93